With a compound annual growth rate of 6.5% between 2024 and 2029, the global pharma packaging market is anticipated to grow from USD 37.5 billion in 2024 to USD 51.4 billion in 2029. Amidst these market trends, Medicap Healthcare Limited is gearing up for the Medicap Healthcare Limited IPO.
According to the Medicap Healthcare Limited IPO review, the IPO is being registered by KFin Technologies Limited, while Aryaman Financial Services Limited will manage the issue. Don’t forget to view the Medicap Healthcare Limited IPO allotment status.
For a detailed and more nuanced Medicap Healthcare Limited IPO review, view the DRHP.
Note: 50% shares will be unlocked 30 days after allotment, while the rest will be free from lock-in restrictions after 90 days.
The Medicap Healthcare Limited IPO review, discussed in this section, contains a detailed breakdown of all key Medicap Healthcare Limited IPO highlights, such as the Medicap Healthcare Limited share price, size, timeline and more.
Issued on 22 September 2025, the Medicap Healthcare Limited IPO DRHP does not contain the issue and open and close dates. Investors can wait for the IPO RHP to shed further light on the same.
The primary strengths and risks of Medicap Healthcare Limited and its IPO are discussed below.
Strengths
Position: The dominant and significant market share demanded by the company allows it to make the best of favourable industry trends.
Strategic Location: The technical strength and strategic location of the manufacturing unit allow quality-centric and precision-driven manufacturing.
Stakeholder Relationship: Long-standing relationships with customers and suppliers help develop a favourable business environment.
Specialisation: Niche and specialised production helps meet unique customer needs, thereby driving fiscal growth.
Risks
Portfolio Concentration: 85.84% came from the sale of Euro Head Caps alone in FY 2025. This trend is consistent from 2024 and 2023, as well.
Customer Concentration: The top 10 customers of the company contributed 77.12% of revenue. In 2024 and 2023, it was over 80%.
Compliance: The final customer of the company is the healthcare industry, which is subject to strict regulatory, quality and other compliance requirements.
Regional Concentration: The company has only one manufacturing unit in Gujarat. Moreover, the revenue is also concentrated in the western region.
As of 14 October 2025, the Medicap Healthcare Limited IPO GMP is not available. However, for a complete breakdown of the Medicap Healthcare Limited IPO, don’t miss out on the offer documents.
Moreover, GMP changes often. Check the latest GMP here.
You must also find the live subscription numbers. Apply now.
1. What is the Medicap Healthcare Limited IPO GMP?
As of 14 October 2025, the Medicap Healthcare Limited IPO GMP is unavailable. However, it may change soon. For the latest sentiment, you can look for the GMP updates.
2. What is the Medicap Healthcare Limited IPO date?
The open and closing dates of the Medicap Healthcare Limited IPO are still unavailable. But one can monitor live subscription details in real time.
3. What is the Medicap Healthcare Limited IPO price?
The Medicap Healthcare Limited IPO DRHP states the issue size to be ₹ 240 Crores. Moreover, the final issue price is not available as of 14 October 2025. Don't forget to check the allotment details.
4. Do I need a demat account to bid for the Medicap Healthcare Limited IPO?
Yes, a demat account is required to bid for the Medicap Healthcare Limited IPO. Click here to get the ultimate list of the top demat account providers.
